- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05342454
Een uitgebreide klinische fMRI-softwareoplossing om kritieke functionele netwerken en cerebrovasculaire reactiviteit in de hersenen in kaart te brengen
Our preliminary work demonstrates that an integrated fMRI software solution, incorporating tb-fMRI, rs-fMRI, and CVR mapping, is clinically feasible and helps clinicians plan brain tumor resection. We have developed a novel automated seed selection method that can accurately map language networks from rs-fMRI. We hypothesize that our innovative approach to enhance, optimize, and validate our preliminary software and integrate it with an established fMRI platform will create robust solutions for clinical RSN and CVR mapping. Partnering with NordicNeuroLab (NNL) will leverage the professional software development by a seasoned commercial MRI software producer in coordination with leading clinical and research experts at MD Anderson. The research will be conducted through three specific aims:
- Develop a clinical software platform for mapping RSNs and determine optimized workflow for presurgical localization of eloquent areas.
- Develop a clinical software platform for mapping CVR and determine optimized workflow for identifying and visualizing brain areas with potential false-negative fMRI results.
- Test and validate RSN and CVR mapping software in patients undergoing neurosurgery.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Primary Objectives:
To validate resting-state fMRI (rs-fMRI) mapping of language and motor (hand and tongue) areas obtained by using the software developed in this research: We will test the non-inferiority of rs-fMRI comparing to task-based fMRI (tb-fMRI) by using intra-operative direct cortical stimulation as the gold standard.
To test whether CVR mapping using the software developed in this research will increase confidence of fMRI mapping of language and motor (hand and tongue) areas: We will test whether the accuracy of fMRI, assessed by using intra-operative direct cortical stimulation as the gold standard, will improve after incorporating the CVR mapping.
Secondary Objectives:
To optimize the rs-fMRI and CVR mapping software during the development phases and to test feasibility of the post-processing workflow using clinical images.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Ho-Ling Liu, PhD
- Telefoonnummer: (713) 563-7383
- E-mail: hlaliu@mdanderson.org
Studie Locaties
-
-
Texas
-
Houston, Texas, Verenigde Staten, 77030
- Werving
- M D Anderson Cancer Center
-
Contact:
- Ho-Ling Liu, PhD
- Telefoonnummer: 713-563-7383
- E-mail: hlaliu@mdanderson.org
-
Hoofdonderzoeker:
- Ho-Ling Liu, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
For the prospective study we will include 120 patients with brain tumors.
For the retrospective study, we will review up to 1600 patients all clinical presurgical fMRI studies performed on brain tumor patients at the MD Anderson since 5/2004.
Beschrijving
Inclusion criteria:
- patient must be >/= 18 years of age;
- patients who will undergo neurosurgical resection of brain tumors;
- patients who will undergo presurgical fMRI as standard of care;
- patients who on neurosurgical evaluation will undergo direct cortical stimulation (DCS) as standard of care.
For the retrospective study, we will review up to 1600 patients all clinical presurgical fMRI studies performed on brain tumor patients at the MD Anderson since 5/2004.
The inclusion criteria:
- patients must be >/= 18 years of age;
- patients who had the presurgical fMRI that contained at least one task-based fMRI scan.
Exclusion Criteria:
Exclusion criteria for the prospective study:
- patients cannot give informed consent;
- patients cannot undergo MRI examinations;
- patients who are indicated for speech fMRI only but cannot comply with any of the speech tasks based on the evaluation of a clinical neuropsychologist.
Exclusion criteria for the retrospective study:
- all fMRI scans were contaminated by head motions (translation > 2 mm or rotation > 2 degrees);
- only speech fMRI paradigms were performed, and patients were not able to comply with any of the speech tasks based on the evaluation of a clinical neuropsychologist.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: CASE_ONLY
- Tijdsperspectieven: OTHER
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Valideer de rusttoestand fMRI (rs-fMRI) mapping van taal- en motorische (hand en tong) gebieden verkregen met behulp van de software die in dit onderzoek is ontwikkeld.
Tijdsspanne: Door afronding van de studie gemiddeld 1 jaar
|
Door afronding van de studie gemiddeld 1 jaar
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Ho-Ling Liu, PhD, M.D. Anderson Cancer Center
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2021-0791
- NCI-2022-00369 (Andere identificatie: NCI-CTRP Clinical Trials Reporting Process)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .